{"id":"W6995590984","doi":"","title":"Pharmacy Choice - Pharmaceutical News - Enanta Pharmaceuticals Posts 3rd Quarter Financial Results [Manufacturing Close - Up]","year":2014,"lang":"en","type":"other","venue":"","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Pharmacy; Community pharmacy; Pharmaceutical industry; Financial Audit","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001434768,0.000749879,0.0007618465,0.002855654,0.002175503,0.00825211,0.001200482,0.004534541,0.4714632],"category_scores_gemma":[0.00831806,0.0005476476,0.000703716,0.003462566,0.0005645754,0.002381561,0.001404055,0.003498279,0.2157446],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004295721,"about_ca_system_score_gemma":0.005976034,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0318829,"about_ca_topic_score_gemma":0.08092291,"domain_scores_codex":[0.9986399,0.0001006223,0.00005084171,0.0001428691,0.0007972248,0.0002685113],"domain_scores_gemma":[0.995615,0.0007591518,0.0003789876,0.0003188879,0.001679025,0.001248871],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005327313,0.00005638528,0.000323513,0.00004538607,0.000004612778,0.00002102777,0.000008109329,0.00007551446,0.00004565427,0.003403483,0.9838018,0.0121611],"study_design_scores_gemma":[0.00005945432,0.00004959604,0.008635255,0.0001346634,0.000009312227,0.00003443703,0.00005730593,0.0004450501,0.0004358192,0.002959983,0.987152,0.00002709696],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.001731319,0.001902082,0.0003627613,0.01071992,0.002544936,0.0001317058,0.04230602,0.00095458,0.9393467],"genre_scores_gemma":[0.005578966,0.0007574621,0.0002087641,0.001493812,0.0008496038,0.00006053317,0.007181616,0.0003202089,0.983549],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.4714632,"threshold_uncertainty_score":0.7538936,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07110142399607393,"score_gpt":0.3402218536936654,"score_spread":0.2691204296975914,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}